SEC Form 4 · accession 0000899243-15-002400
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan C. Herman
Officer — Chief Scientific Officer
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Aug 3, 2015 | M | 14,166 | $0.4168 | A | 228,865 | D | |
| Common Stock, $0.0001 par value | Aug 3, 2015 | S | 14,166 | $34.8308 | D | 214,699 | D | |
| Common Stock, $0.0001 par valueF2 | holding | — | — | — | 300,164 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $0.4168 | Aug 3, 2015 | M | 14,166 | D | — | Jul 17, 2021 | Common Stock | 14,166 | 91,360 | D |
Explanation of responses
- F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- F2These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.
- F3The shares underlying this option are vested and exercisable as of the date hereof.